ABSTRACT. Dietary carotenoids, particularly beta-carotene, have in many epidemiologic studies been associated with a decreased risk of cancer. Experimental studies have been inhibited by difficulties in delivering these molecules to target cells. A novel delivery system has been developed in the mouse 10T1/2 cell line. With these cells several carotenoids of dietary and commercial interest have been shown capable of inhibiting carcinogen-induced neoplastic transformation. Their action appears qualitatively similar to the previously documented action of retinoids (vitamin A derivatives) in this cell system, in that inhibition occurs in the post-initiation phase of carcinogenesis, but higher concentrations (10-1000 fold) are required. Both types of compound were found to strongly upregulate gap junctional intercellular communication (GJC) and these activities were statistically correlated. Up-regulation of gap junctional intercellular communication was caused by the increased expression of connexin 43 (Cx43) at the message and protein level. Cx43 is one member of a family of gap junctional structural proteins. While protection from carcinogen-induced neoplastic transformation cannot be directly studied in human cells, we have shown that Cx43 expression is also up-regulated in human fibroblasts, suggesting that carotenoids have chemopreventive action in humans. We have proposed that increased junctional communication is mechanistically linked to inhibition of transformation in 10T1/2 cells. In this model, the gap junction serves as a conduit for growth regulatory signals from normal to carcinogen-initiated cells, thereby suppressing their transformation.
INTRODUCTION

Carotenoids as cancer preventive aaents : Studies in Humans
The concept that carotenoids play a preventive role in human cancer has undergone much revision in recent years. The results to be presented here indicate that further revision may be necessary. For many years the only known function of carotenoids in human nutrition was the role of beta-carotene, and a few of the other carotenoids found in the human diet, as a source of vitamin A. Vitamin A, and more specifically retinoic acid, was known to be a potent regulatory factor of epithelial cell differentiation (ref. I), and, in many studies in experimental animals and in cell cultures, had been shown to act as a potent cancer chemopreventive agent (refs. 2,3) . Thus, it was not unexpected when several epidemiologic studies demonstrated an inverse correlation between consumption of foods rich in vitamin A and pro-vitamin A carotenoids and future incidence of cancer (reviewed in ref. 4). These findings appeared to confirm other studies which had revealed a similar inverse correlation between serum retinol levels and cancer risk (refs. 43) . Re-assessment of these conclusions occurred as a result of two events: first a re-evaluation of the blood retinol data which revealed that low retinol values occurred only in subjects whose blood was obtained within about 2 years of the diagnosis of cancer (ref. 6) (i.e lowered serum retinol was most likely a consequence of pre-clinical disease); second, a seminal paper by Sporn and Pet0 (ref. 7) in which it was argued that it was the beta-carotene component of the diet that was responsible for the observed epidemiologic findings. Many'subsequent epidemiologic studies have statistically separated the carotenoid component of the diet from the pre-formed retinoid component, and have repeatedly demonstrated, particularly in the case of lung cancer, that populations who consume diets rich in carotenoid-containing foods have a lower risk of cancer than those who do not (ref. 8 ) . However, because such diets contain many other potentially protective substances, the-cause-and-effect relationship remains to be proven. To test this hypothesis, multiple cancer chemoprevention intervention trials using beta-carotene are currently on-going. The largest involves 20,000 physicians in the U.S.A. who have been taking 25mg beta-carotene every other day for 10 years. with calf serum and 25 pg/ml gentamycin. They were exposed to 3 pg/ml methylcholanthrene (MCA) in acetone for 24 hr, one day after seeding then, 7 days after removal of the carcinogen, were given the stated concentration of carotenoid dissolved in tetrahydrofuran (THF). Cultures were re-fed and retreated with carotenoid every 7 days. Control cultures received acetone plus MCA or acetone plus THF. Numbers of morphologically transformed foci were evaluated 42 days after seeding the cultures as described (ref. 12) . Communication assays. Cell cultures were seeded as above and treated with carotenoids as in the transformation experiments. After 14, 24 and 34 days of treatment, intercellular communication was assessed by microinjection of the junctionally permeable fluorescent dye Lucifer Yellow into approximately 20 randomly chosen cells. Communication, measured as the number of fluorescent cells surrounding each injected donor cell, was assessed 10 minutes after injection as described (ref. 13). Molecular studies. Western blotting and immunofluorescence studies on intact cells were performed with a rabbit polyclonal antibody raised against a synthetic peptide corresponding to the C-terminal 15 residues of the predicted sequence of connexin 43 (ref. 14) . Northern blotting of total cellular RNA was performed at high stringency with 32P-labelled full-length cDNA to connexin 43, a gift of E. Beyer (ref. 14) .
CAROTENOIDS INHIBIT CHEMICALLY-AND PHYSICALLY-INDUCED NEOPLASTICALLY TRANSFORMED FOCI IN C3HlOTl12 CELLS.
In order to examine the chemopreventive action of the carotenoids, 10T1/2 cells were induced to undergo neoplastic transformation by exposure to either a chemical carcinogen, 3-methylcholanthrene, or to 600 rad X-irradiation. These cultures respond to carcinogenic insult by the production of foci of carcinogen-induced neoplastic transformed cells 4-5 weeks after exposure. Nontoxic concentrations of carotenoids, dissolved in THF, were added to 10T1/2 cells 7 days after removal of 3-methylcholanthrene or 8 days after X-irradiation, and were maintained in the cultures for the remaining 4-week duration of the experiment. Treatment resulted in a dose-dependent reduction in the formation of carcinogen-induced neoplastically transformed foci. As seen in Figs. 1 and 2, a concentration of 1 O-5M beta-carotene or canthaxanthin virtually completely eliminated transformed foci, but continuous treatment was required. If carotenoids were removed after four weeks treatment, foci appeared in carcinogen-treated cultures after a 3-5 week latent period. Addition of carotenoids prior to and during carcinogen exposure, or after neoplastic transformation had occurred, had little influence on the formation of carcinogen-induced transformed foci. It may therefore be concluded that carotenoids act in the post-initiation phase of carcinogenesis by reversibly suppressing the ability of carcinogen-initiated cells to undergo neoplastic transformation. Might this similarity of biological action imply similar molecular action? Unfortunately the mode of action of carotenoids as cancer chemopreventives is poorly understood at the molecular level. Previously, carotenoids had been considered to have two possible functions in mammals: to be metabolized to retinoids, for that limited group of compounds capable of such conversion (the provitamin A carotenoids), and to act as lipid-phase antioxidants. This latter activity is shared by all carotenoids but to differing degrees. Our results presented above suggested that the action of carotenoids may be due to their conversion into retinoids in cell cultures. However, on a chemical basis, this explanation appears improbable; canthaxanthin, which is marginally more active than betacarotene in 10T1/2 cells, is not a pro-vitamin source in mammals. We have furthermore demonstrated that lycopene, an acyclic carotenoid, (ref. lo), and a synthetic C-22 carotenoid analogue (8,13-dimethyC2,2,19,19-tetramethoxy-eicosa-4,6,8,10,12,14,16-heptaene-3,18-dione (ref. 15) , are active in 10T1/2 cells as inhibitors of transformation. Conversion of these compounds to retinoids seems most unlikely. Even for beta-carotene, the carotenoid with the highest pro-vitamin A activity in mammals, we were not able to detect the expected products of its conversion into retinoids after exposure of To determine if carotenoids share with retinoids this ability to up-regulate junctional communication, 10T1/2 cells were exposed to carotenoids under the conditions of the transformation assay, and at various periods thereafter junctional communication was measured by dye-injection. As shown in Figure 4 , carotenoid treatment caused a progressive increase in junctional communication after a delay of about 4 days. This increase was maintained over the 4 week experimental period; the same treatment period used in the transformation assays. Dose-response studies demonstrated that a good correlation existed between the ability to inhibit transformation and to induce gap junctional communication. Thus beta-carotene and canthaxanthin were approximately equipotent in both assays, while Me-bixin for example, was without activity in either of the assays (Figure 5 ). Although the carotenoids produced a similar magnitude of induced GJC as did the retinoids, this activity required higher concentrations (up to 1000-fold, depending on the compound) and longer treatment times (3-4 days vs. 1 day for retinoids). . When Northern and IWestem blots were performed on total mRNA and protein respectively, isolated from beta-carotene or canthaxanthin treated 10T1/2 cells, a major increase in connexin 43 gene products was observed in response to both carotenoids tested. On Western blots, an increased immunolabelling of two bands in the 43-45kD region by the anti-connexin 43 antibody was seen (Fig. 6) When carotenoid treated cells were processed for indirect immunofluorescence using the same connexin 43 antibody as used in the Western blots, a major increase in immunofluorescent plaques was observed in regions of cell-cell contact (Figs. 7C,D) . These plaques are the presumed sites of aggregation of individual connexons to form the junctional complexes which have been visualized by electron microscopy of other junctionally communicating cells. Thus the increased amounts of connexin 43 detected by Western blotting became localized in regions of the cell where they could contribute to the carotenoid-enhanced junctional communication detected by the dye transfer experiments. Effects in human cells. Addition of beta-carotene, canthaxanthin or lycopene to early passage human dermal fibroblast cells has recently been shown to up-regulate gap junctional communication and the expression of Cx43. These effects were produced at concentrations between 10-6 and IO-SM, as in 10T1/2 cells (data not shown). Effects on carcinogenesis could not be determined because human cells have so far resisted attempts to transform them with carcinogens Do carotenoids up-regulate other retinoid-responsive aenes? The conclusion that carotenoids do not act through conversion to retinoids was primarily based on chemical evidence: the absence of C-14 labeled retinoids after incubation with C-14 beta-carotene, and the activity of non pro-vitamin A carotenoids in our assay system. However the possibility exists that at high concentration, carotenoids may possess weak activity as retinoid agonists. To test this we investigated the potential for carotenoids to activate a known retinoid-responsive gene. We chose to examine RAR-beta. This nuclear retinoid receptor(RAR), is retinoid-inducible in a wide variety of cell types and has been shown to possess a retinoic acid responsive element (RARE) in its promoter region (ref. 32) . In both TI12 and F9 teratocarcinoma cells retinoids up-regulated expression of both connexin 43 and RAR-beta as expected. However, when we added canthaxanthin to these cultures, chosen because of its chemical purity and stability, only Cx43 was up-regulated at the message level (ref. 33). These results imply that carotenoids and retinoids function through separate but overlapping pathways We are currently investigating whether retinoid and/or carotenoid responsive elements exist in the promoter region of the Cx43 gene.
Proposed sianificance of up-reaulated aaD iunctional communication The consistent association between enhanced gap junctional communication, suppression of neoplastic transformation and augmented growth control of both normal and neoplastic cells (refs. 19,21,34) , strongly supports the argument for a functional role for junctionally transmitted signals in these events. In our proposed model of carotenoid and retinoid action, the increased gap junctional communication caused by these compounds places carcinogen-init'ated cells within an expanded communicating network. This will usually be dominated by normal cells since, both in vifm and in vivo, initiation appears to be a rare event. This increased communication, which as discussed above is associated with enhanced growth control, acts to stabilize the initiated cell and prevent its neoplastic transformation. A major question not yet addressed in our studies, is the chemical nature of the putative growth regulatory signal(s) that is transferred through gap junctions. Because of the constraints of the junctional pore, such signals must be below about 1000 daltons in size; because the pore is waterfilled the signals should be water-soluble, and, to exclude passive transfer through adjacent plasma membranes, the signals should be electrically charged. Clearly, properties of physiologically active ions such as Ca++, or second messengers such as CAMP, satisfy these criteria and both are known to traverse the junction (refs. 30,31) . One of the next phases of research in this area will be to devise appropriate methods to test the effects of such ions and molecules on growth control and neoplastic transformation.
